Former President Donald Trump has pledged to grant Robert F. Kennedy Jr. full authority over health, food, and medicine issues if he wins a second term. This controversial move has sparked debate, with critics expressing concerns about Kennedy’s stance on vaccines and the potential impact on public health.
Sanofi SA reported impressive third-quarter results, exceeding analysts’ expectations with strong sales growth fueled by its blockbuster eczema drug Dupixent, new pharmaceutical launches, and vaccine performance. The company also provided an updated outlook for 2024, reaffirming its confidence in Dupixent’s continued success and anticipating strong growth in vaccine sales.
SK bioscience, a leading South Korean vaccine and biotech company, has invested $3 million in FinaBio, a US-based biotech specializing in next-generation conjugate vaccine technology. This strategic investment will allow SK bioscience to enhance the immunogenicity and productivity of its existing conjugate vaccines, including those for pneumonia and typhoid. The collaboration will also accelerate SK bioscience’s global expansion plans.
Africa is facing a major mpox outbreak, with over 25,000 cases and 643 deaths reported in 2024. However, high vaccine costs are hindering efforts to contain the spread, leaving many African nations reliant on donations. The situation underscores the urgent need for affordable and accessible vaccines to protect vulnerable populations.
Bill Gates has addressed the widespread conspiracy theory that he is implanting microchips in COVID-19 vaccines, expressing his bewilderment at the claims. He also clarified his extensive farmland purchases, stating that his goal is to increase productivity and create jobs. Gates’ responses are crucial in combating misinformation and restoring public trust in vaccines.
The Democratic Republic of Congo received its first shipment of mpox vaccines on Thursday, marking a significant step in combating the ongoing outbreak. This comes after the World Health Organization declared the mpox outbreaks in 12 African countries a global health emergency. The vaccines, donated by the European Union, are expected to help address the inequity in access to vaccines between African nations and wealthier countries.
The global medical refrigeration market is expected to experience significant growth, reaching a valuation of US$ 7.2 billion by 2034, driven by factors such as increasing immunization programs, advancements in biopharmaceutical research, and the rising prevalence of chronic diseases. Key market players are focusing on product launches and expanding their presence globally.
Molecular Assemblies, a leader in enzymatic DNA synthesis, has received an additional $4 million from DARPA to further develop its technology for on-demand DNA vaccine manufacturing. The company’s Fully Enzymatic Synthesis (FES) technology is being used in the DARPA NOW project to create a mobile platform for rapid production of DNA-based vaccines and therapeutics anywhere in the world.
Robert F. Kennedy Jr., founder of the Children’s Health Defense, has won a legal victory against the Biden administration, with a federal judge ruling that he can sue over alleged social media censorship of his organization’s vaccine-related content. This victory comes shortly after Kennedy suspended his presidential campaign and endorsed former President Donald Trump.
The World Health Organization (WHO) has eased its rules, allowing organizations like Gavi and UNICEF to purchase mpox vaccines before WHO approval, aiming to expedite vaccine distribution to Africa amidst a growing outbreak. This decision comes as the WHO is expected to grant emergency use authorization to two vaccines in September. The move addresses concerns about potential delays in vaccine access for low-income countries.
